Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001207061 | SCV001378400 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2019-06-26 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with lysine at codon 646 of the PRX protein (p.Glu646Lys). The glutamic acid residue is weakly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs750625856, ExAC 0.02%). This variant has been observed in combination with a different variant in the PRX gene in an individual affected with hereditary motor and sensory neuropathy (PMID: 28708278). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |